Lumen Specialty Pharmacy On track
Specialty pharmacy · Minority equity · $19.5M deployed · Last report Oct 5
Covenants
All 4 passingTightest: net leverage, 31.1% roomAs of Sep 30 · senior lender covenants Thorne monitors, certified quarterly
Net leverage
Passing
- Required
- Actual
- ≤ 4.50x
- 3.10x
Room left31.1%
- Earnings can fall $3.6M before a breach.
- No breach expected in the base plan.
Debt service coverage
Passing
- Required
- Actual
- ≥ 1.20x
- 1.88x
Room left56.7%
- Earnings can fall $4.2M before a breach.
- No breach expected in the base plan.
Equipment spending
Passing
- Required
- Actual
- ≤ $2.5M / yr
- $1.4M
Room left44%
- $1.1M left this year.
- A cold storage upgrade is planned.
Minimum cash
Passing
- Required
- Actual
- ≥ $2.0M
- $6.8M
Room left240%
- Lowest point ahead: $7.0M on Nov 13.
- Every forecast week clears the minimum.
Compliance certificates
- In draftQ3 compliance certificateDue Nov 14 (45 days after quarter end)
- AcceptedQ2 compliance certificateFiled Aug 11
- AcceptedQ1 compliance certificateFiled May 12
What could change this
- Losing one large payer contract would cut earnings by about $1.4M.
- A new state license opens two more markets from Q2.
- Paying a special dividend would lower cash but leave covenants intact.
New marks a measure Your Cohort adds to Thorne’s reporting · fictional companies and figures · thresholds are placeholders · select or hover any dotted label for its definition
